VivoSeq
Other

Tooth Extraction

1

Pipeline Programs

3

Active Trials

4

Companies Involved

Tooth Extraction is an early-stage landscape with 1 program across 4 companies. The most active players are GSK, Unither Pharmaceuticals, France, iX Biopharma Ltd.. 1 therapy is approved.

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

11/100

Mech. Concentration

100/100

Completion Rate

94/100

Attrition Rate

5/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs

Trial Status

22

clinical trials

Completed17 · 77%
Not yet recruiting3 · 14%
Withdrawn1 · 5%
Unknown status1 · 5%

Trial Activity

22 trials

Evaluation of Antibiotic Administration Following Tooth Extraction
Not yet recruiting··N/A·NCT06502288·152 enrolled
Dental Pain (Following Third Molar Tooth Extraction) Study
Completed·GSK logoGSK·Phase 3·NCT00114049·300 enrolled
SB-705498 Dental Pain Study After Tooth Extraction
Completed·GSK logoGSK·Phase 2·NCT00281684·145 enrolled
Dental Pain 3rd Molar Tooth Extraction GW842166
Completed·GSK logoGSK·Phase 2·NCT00444769·112 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)